Region Syddanmark   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Vejle Denmark (1890)

Organization Overview

First Clinical Trial
2001
NCT01513564
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Connie Thuree Nielsen, consultant, MD, ph.d | Department of Oncology, Vejle Hospital - University Hospital of Southern Denmark | Henrik Jensen, Dept. of Oncology, Vejle Sygehus, Vejle, Denmark | Karen Hoejmark Hansen | Kolding Sygehus | Medical Dept.,Kolding Hospital, SLB, Denmark | Region Syddanmark | Sygehus Lillebaelt | Sygehus Lillebælt | Sygehus Lillebælt, Kolding | Vejle Hospital | Vejle Hospital, Lillebaelt Hospital

Active Ingredients

Drugs in Phase 4 Trials (19)

bacille calmette-guerin (1 trial)

blood plasma (1 trial)

buprenorphine (1 trial)

dexamethasone (3 trials)

epinephrine (levophed) (3 trials)

escitalopram (lexapro) (1 trial)

gabapentin (neurontin) (1 trial)

ketorolac (acuvail) (2 trials)

levobupivacaine (chirocaine) (2 trials)

melatonin (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

oxycodone (oxycontin) (1 trial)

oxygen (1 trial)

oxytocin (syntocinon) (1 trial)

ropivacaine (naropin) (1 trial)

sodium chloride (3 trials)

tranexamic acid (cyklokapron) (1 trial)

urea (4 trials)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (22)

acetaminophen (tylenol) (2 trials)

atorvastatin (lipitor) (1 trial)

capecitabine (xeloda) (10 trials)

carboplatin (paraplatin) (3 trials)

cefazolin (ancef) (1 trial)

ciclesonide (alvesco) (1 trial)

cisplatin (platinol) (1 trial)

daratumumab (darzalex) (2 trials)

fexofenadine (allegra) (1 trial)

fluorouracil (efudex) (4 trials)

gentamicin (garamycin) (1 trial)

i-factor (1 trial)

irinotecan (Camptosar) (4 trials)

lenalidomide (revlimid) (3 trials)

leucovorin (4 trials)

methylprednisolone (medrol) (1 trial)

ocrelizumab (ocrevus) (1 trial)

oxaliplatin (eloxatin) (7 trials)

rituximab (rituxan) (1 trial)

tocotrienol (7 trials)

vancomycin (Vancocin) (1 trial)

vinorelbine (navelbine) (4 trials)

Drugs in Phase 2 Trials (24)

acetylcysteine (mucomyst) (1 trial)

atropine (1 trial)

bevacizumab (avastin) (5 trials)

bortezomib (velcade) (2 trials)

cabazitaxel (jevtana kit) (2 trials)

cyclophosphamide (cytoxan) (2 trials)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (2 trials)

epirubicin (ellence) (1 trial)

gemcitabine (gemzar) (5 trials)

paclitaxel (taxol) (1 trial)

panitumumab (vectibix) (6 trials)

pembrolizumab (keytruda) (1 trial)

pemetrexed (alimta) (1 trial)

pertuzumab (perjeta) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

sarilumab (kevzara) (1 trial)

simvastatin (zocor) (1 trial)

temsirolimus (torisel) (1 trial)

tocilizumab (actemra) (1 trial)

topotecan (hycamtin) (1 trial)

trastuzumab (herceptin) (2 trials)

veliparib (2 trials)

zoledronic acid (zometa) (1 trial)

Drugs in Other Trials (12)

4-aminopyridine (1 trial)

bovine colostrum (1 trial)

corn oil (1 trial)

estrogen (1 trial)

fish oil (Omegavan) (1 trial)

human milk (1 trial)

hydroxyethyl starch (1 trial)

iron isomaltoside (1 trial)

lidocaine (xylocaine) (1 trial)

morphine (1 trial)

polyethylene glycol (1 trial)

teriparatide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Asthma (Phase 3)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Bipolar Disorder (Phase 2)

Bone Marrow Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Cholangiocarcinoma (Phase 2)

Chronic Pain (Phase 4)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Constriction, Pathologic (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Disease (Phase 4)

Disease Progression (Phase 4)

Dyssomnias (Phase 4)

Fasciitis (Phase 4)

Fasciitis, Plantar (Phase 4)

Hyperkinesis (Phase 4)

Intestinal Diseases (Phase 2)

Intestinal Neoplasms (Phase 2)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Lung Neoplasms (Phase 3)

Mood Disorders (Phase 4)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Chronic Progressive (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Myopia (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Osteoarthritis, Hip (Phase 4)

Osteoarthritis, Knee (Phase 4)

Ovarian Neoplasms (Phase 2)

Pain, Postoperative (Phase 4)

Parasomnias (Phase 4)

Postoperative Complications (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Rectal Neoplasms (Phase 2)

Sclerosis (Phase 3)

Seasonal Affective Disorder (Phase 4)

Sleep Wake Disorders (Phase 4)

Spinal Stenosis (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 70
  • # of Trial APIs: 77